Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_assertion type Assertion NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_head.
- NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_assertion description "[These results have led to a multicenter, randomized, placebo-controlled efficacy trial of ALB in acute ischemic stroke-the ALIAS Phase III Trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_provenance.
- NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_assertion evidence source_evidence_curated NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_provenance.
- NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_assertion SIO_000772 16809570 NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_provenance.
- NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_assertion wasDerivedFrom ctd_human-20130708 NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_provenance.
- NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_assertion wasGeneratedBy ECO_0000218 NP8282.RAUbz_g5BSOEhi6knDxffuHA0OMa--gnIfiTOu2qXDOYQ130_provenance.